London listed teleradiology provider Medica Group has agreed to acquire US-based imaging contract research organisation (iCRO) RadMD, paving its way for entry into the $1bn global clinical trial imaging market. The acquisition price of up to $21.7m (c. £15.6m) comprises an initial cash consideration of $16.3m and deferred consideration of up to $5.4m based on the company’s…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
 RadMD, paving its way for entry into the $1bn global clinical trial imaging market.){kind=link}